The Hindu·4 min read·hard

Girl’s death in China: Does gene editing therapy need better regulation? | In Focus Podcast

Z
Zubeda Hamid
Girl’s death in China: Does gene editing therapy need better regulation? | In Focus Podcast
AI Summary

The death of a six-year-old girl in China following experimental gene editing therapy has sparked a global debate on medical ethics and regulation. Experts are questioning the oversight of experimental treatments and the risks associated with base editing in clinical settings.

The scientific world was rocked last month, when the case of a six-year-old girl who died in China, surfaced. The child was believed to have Snijders Blok-Campeau syndrome, a rare neurodevelopmental disorder caused by a mutation in the CHD3 gene. The condition affects intellectual development, but its severity varies widely. The girl’s parents sought an experimental treatment led by neuroscientist Zilong Qiu at the Shanghai Jiao Tong University.

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
healthscienceworld

Get the full story

Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.

Create free account

Already have an account? Sign in